ABSTRACT. Obesity has long been known for its deleterious consequences on cardiovascular outcomes. Recent studies have suggested that extra pounds are beneficial for heart failure (HF) patients, while weight loss and cachexia may be markers of poor clinical outcomes in the setting of chronic HF. Nevertheless, the implications of obesity, weight reduction, and cachexia in patients receiving cardiac resynchronization therapy (CRT) is less known. In this short communication, we review current literature on the effects of obesity, weight loss, and cardiac cachexia (the Good, the Bad, and the Ugly) on outcomes in HF patients, with a focus on those receiving CRT. We further offer our perspectives on the clinical applications of current research.